IPO Trending
QLINESME / NSEListed

Q-Line Biotech Limited

Q-Line Biotech Limited is a healthcare diagnostics company engaged in the manufacturing and supply of In-Vitro Diagnostic (IVD) products, pathology reagents, rapid test kits, and laboratory equipment for hospitals, diagnostic laboratories, and healthcare institutions across India. Established in 2010, the company focuses on affordable diagnostic solutions and operates in the medical diagnostics and healthcare consumables segment, with its proposed IPO planned for listing on the NSE EMERGE SME platform.

₹326 - ₹343102.49x sub
Listed Price452.00
Listing Gain+31.78%
TimelineBookbuilding IPO
Open21 May 2026
Close25 May 2026
Allotment26 May 2026
Listing29 May 2026

Quota Reservation Portions

AnchorPortion: 17,81,200 shares
28.48%
QIBPortion: 11,88,000 shares
19%
HNIPortion: 8,91,600 shares
14.26%
RetailPortion: 20,79,200 shares
33.25%
Market MakerPortion: 3,13,200 shares
5.01%

Minimum Application Bracket Matrix

Retail2 lots / 800 shares
₹2,74,400
sHNI3 lots / 1,200 shares
₹4,11,600
bHNI8 lots / 3,200 shares
₹10,97,600

About the Company

Q-Line Biotech Limited is a healthcare diagnostics company engaged in the manufacturing and supply of In-Vitro Diagnostic (IVD) products, pathology reagents, rapid test kits, and laboratory equipment for hospitals, diagnostic laboratories, and healthcare institutions across India. Established in 2010, the company focuses on affordable diagnostic solutions and operates in the medical diagnostics and healthcare consumables segment, with its proposed IPO planned for listing on the NSE EMERGE SME platform.

Company Promoters

Saurabh GargAmita GargAyush GargAjay Kumar MahantyAbhay Agrawal
Q-Line Biotech Limited IPO Details | GMP, Allotment & Financials | IPO Trending